Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39306

DNAJC5 Knockout HAP1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone Marrow

  • Disease:

    Chronic myeloid leukemia

The DNAJC5 Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal population of HAP1 cells with targeted disruption of the DNAJC5 gene, encoding the synaptic co-chaperone CSP??. This knockout model enables investigation of CSP????s role in recruiting Hsc70 to SNARE complex proteins (SNAP-25, syntaxin, VAMP2) and its function in preventing protein aggregation. HAP1 is a near-haploid human cell line ideal for loss-of-function studies. This DNAJC5 knockout pool is suited for applications such as modeling Kufs disease, studying chaperone-mediated synaptic dysfunction, and performing protein aggregation assays, western blotting, and co-immunoprecipitation.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HAP1

    Sex of Donor

    Male

    Age

    40 years

    Derived From Site

    Bone marrow

    Gene Name

    DNAJC5

    Gene Identifier

    NCBI Gene ID 80331

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    IMDM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC5 Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of HAP1 cells with targeted disruption of the DNAJC5 gene. This polyclonal knockout pool provides a loss-of-function model for studying the co-chaperone CSP??, encoded by DNAJC5. The use of a polyclonal format enables robust gene disruption across the cell population, allowing researchers to perform biochemical and functional assays without clonal isolation. This product is designed for applications requiring population-level knockout effects, such as protein interaction and aggregation studies.

HAP1 is a near-haploid human cell line derived from the male KBM-7 chronic myeloid leukemia line. Its haploid genome makes it particularly suitable for CRISPR-based knockout studies, as disruption of a single allele typically results in complete gene inactivation. HAP1 cells are widely used in functional genomics and have become a standard system for genome-wide screens. Despite their non-neuronal origin, HAP1 cells express conserved components of exocytic and chaperone pathways, enabling the study of genes like DNAJC5 that play critical roles in neuronal functions.

DNAJC5 encodes cysteine string protein ?? (CSP??), a synaptic vesicle co-chaperone that recruits Hsc70 to SNARE proteins including SNAP-25, syntaxin, and VAMP2, as well as synaptotagmin, to facilitate proper folding and exocytosis. CSP?? activity is regulated by heat shock factor 1 (HSF1) and neuronal activity, and it functions upstream of SNARE complex assembly to maintain presynaptic protein homeostasis. Loss of CSP?? leads to SNARE misfolding and aggregation, contributing to synaptic dysfunction. Dominant mutations in DNAJC5 cause adult-onset neuronal ceroid lipofuscinosis (Kufs disease), and CSP?? dysfunction is linked to synucleinopathies, positioning this gene at the intersection of chaperone-mediated protein quality control and neurodegeneration.

In the HAP1 background, knockout of DNAJC5 enables the dissection of CSP??-dependent chaperone mechanisms in a genetically clean and experimentally accessible system. The haploid nature ensures efficient gene disruption, yielding a consistent loss-of-function phenotype suitable for quantitative assays. Although HAP1 cells are not neuronal, they retain core exocytic and chaperone machinery, allowing researchers to study fundamental CSP?? interactions and functions. This model is particularly useful for co-immunoprecipitation of CSP??-Hsc70-SNARE complexes and for monitoring protein aggregation using established biochemical methods, providing a simplified platform to complement studies in neuronal models.

This DNAJC5 polyclonal knockout pool is a powerful tool for neurodegenerative disease research, including modeling Kufs disease and investigating chaperone-mediated synaptic dysfunction. Researchers can employ these cells in western blotting, RT-qPCR, co-immunoprecipitation, immunofluorescence, and protein aggregation assays to elucidate CSP??’s role in SNARE complex maintenance and to screen for modulators of protein misfolding. For further information or to discuss your specific experimental needs, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)